Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company CSL Ltd.
DescriptionHuman coagulation factor XIII concentrate
Molecular Target Not applicable
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentMarketed
Standard IndicationFactor XIII deficiency
Indication DetailsPrevent bleeding in patients with congenital Factor XIII deficiency; Treat peri-operative surgical bleeding in adult and pediatric patients with congenital factor XIII (FXIII) deficiency
Regulatory Designation U.S. - Accelerated Approval (Prevent bleeding in patients with congenital Factor XIII deficiency)

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today